Heparin is a potent inhibitor of arterial smooth muscle cell (SMC) migration and proliferation in vivo and in vitro. We propose that heparin affects these SMC functions by interfering with either the expression or the activity of secreted proteases required for cell movement. We have reported that heparin selectively inhibits the expression of tissue-type plasminogen activator in SMCs during mitogenesis. In this study we show that the gene expression of another kind of protease, interstitial collagenase, is induced by fetal bovine serum and is also suppressed by heparin. The inhibitory effect on the induced collagenase mRNA is specific to heparin-like molecules and does not depend on the anticoagulant activity of heparin. In an in vitro mitogenesis model, heparin inhibits DNA synthesis and selectively suppresses the transcription of t-PA during mitogenesis.21 The inhibitory effect of heparin is selective since it has no effect on a number of genes that are also modulated.21 In this study, we have investigated the effect of heparin on the gene expression of interstitial collagenase. Collagenase mRNA increases during mitogenesis and is decreased by the addition of heparin. The similarities between the expression of t-PA and collagenase suggest that both genes may share common regulatory elements. We have begun to investigate the effect of heparin on the phorbol ester-responsive element (TRE), which is sufficient to mediate the transcription of the human collagenase gene in response to phorbol esters such as phorbol 12-myristate 13-acetate (PMA).22 A similar, but not identical, sequence has been described in human and mouse t-PA genes.23,24 Our results suggest that heparin decreases collagenase gene expression by suppressing the TRE. 
H eparin is a potent inhibitor of vascular smooth muscle cell (SMC) proliferation and migration. In vivo, it inhibits the initial wave of SMC proliferation induced by arterial injury and the subsequent cell migration to the intima.'2 In vitro, heparin inhibits proliferation and migration of a number of cell types.3-6 How heparin functions has yet to be determined, even though various mechanisms have been proposed. Both in vivo and in vitro, administration of heparin must be started before the cells enter S phase to achieve maximum inhibitory effect. Hence, the heparin block is probably in the G, phase. In some cells, heparin decreases epidermal growth factor binding and inhibits the expression of several oncogenes, including c-myb,8 c-fos, and c-myc. 9 We have focused on the effect of heparin on extracellular proteases and have postulated that heparin affects SMC proliferation and migration by interfering with either the expression or the activity of extracellular proteases, such as plasminogen activators and interstitial collagenase, which are needed for degradation of the surrounding matrix.
The principal function of the plasminogen activators, tissue-type plasminogen activator (t-PA) and urokinase plasminogen activator (u-PA), is to convert plasminogen to plasmin.10." Plasmin degrades a wide range of matrix molecules. Although plasmin does not degrade collagen, it can activate procollagenase to collagenase.'2-14 These proteases may play a role in cell movement. In injured rat carotid artery, medial SMCs express t-PA as they migrate through the internal elastic lamina into the intima. 15 Studies using blocking antibodies have demonstrated the importance of t-PA for endothelial cell migration. '6 Interstitial collagenase is also expressed in migrating endothelial cells'7 and in tumor cells.'819 The importance of interstitial collagenase in tumor cell migration is shown by studies using antibodies or inhibitors of collagenase activity (tissue inhibitor of metalloproteinases) to block tumor invasion. '6,20 In an in vitro mitogenesis model, heparin inhibits DNA synthesis and selectively suppresses the transcription of t-PA during mitogenesis. 21 The inhibitory effect of heparin is selective since it has no effect on a number of genes that are also modulated. 21 In this study, we have investigated the effect of heparin on the gene expression of interstitial collagenase. Collagenase mRNA increases during mitogenesis and is decreased by the addition of heparin. The similarities between the expression of t-PA and collagenase suggest that both genes may share common regulatory elements. We have begun to investigate the effect of heparin on the phorbol ester-responsive element (TRE), which is sufficient to mediate the transcription of the human collagenase gene in response to phorbol esters such as phorbol 12-myristate 13- (Figure  3a) or FBS (Figure 3b) . A weak PKC inhibitor, HA1004,39 had little effect on the induced collagenase mRNA. Moreover, a second dose of PMA (5 ng/ml) did not increase collagenase mRNA in SMCs that had been pretreated with either 100 or 200 ng/ml PMA for 24 hours to deplete the PKC activity (Figure 3c ). These results suggested that the induction of collagenase mRNA by PMA or FBS involved the activation of the PKC pathway.
Effect of Heparin on Phorbol Ester-Responsive Element
Heparin suppresses the expression of both t-PA2' and collagenase mRNAs induced by FBS or PMA. This observation raises the possibility that both genes might share common regulatory elements. We focused on the TRE because it has been shown to mediate the transcription of the collagenase gene in response to phorbol esters. 22 A similar, but not identical, sequence has been described in human and mouse t-PA genes. 2324 We determined the effect of heparin on the TRE by transiently transfecting SMCs with CAT constructs containing either a human collagenase promoter -73/+63 sequence encompassing the TRE or a tandemly linked three-TRE sequence (3xTRE) ( Table 1) . CAT expression from the collagenase promoter sequence was induced in the presence of FBS or PMA (control 9.2±2 1 pmol/hr/mg protein; PMA, 82.4±15.6 pmol/hr/mg protein) and was suppressed by heparin. In a similar manner, FBS or PMA induced the expression of CAT from 3xTRE (control, 38.3±13.9 pmol/hr/mg protein; PMA, 276.8±46.7 pmol/hr/mg protein), and this induction was also suppressed by heparin.
We next examined the specificity of the inhibition for heparin and found that a related glycosaminoglycan, chondroitin-6-sulfate, which did not suppress the PMAinduced collagenase mRNA, also did not affect the a COLLAGENASE GAPD ,sion (68%).
hours. AP-1 binding was low in growth-arrested SMCs. of the transThe binding was increased by PMA and was suppressed Dy transiently by both heparin and IC 1772 (90% inhibition) (Figure  ontaining the  4a) . However, chondroitin-4-sulfate and dermatan sultin promoter fate had no effect (Figure 4a ). Chondroitin-6-sulfate cted cell, and also did not decrease the PMA-induced AP-1 binding Ius, the effect (data not shown). )ression from
The possibility that the decrease in AP-1 binding was not due could be due to residual heparin from medium or matrix by the transduring the isolation of nuclear protein was scriptional factor, NF-kB, was examined. NF-kB bind-60.5 ing was induced by PMA but was not affected by 233 heparin (Figure 4c ). On the other hand, when heparin was deliberately added to the NF-kB binding assay, the (Figure 4d ). Since NF-kB binding was not affected (Figure 4c) TREs in an indiscriminate fashion? Since heparin has no effect on the induction of c-fos and c-jun, which also contain TREs,46'47 these results suggest that heparin's effect on the TRE in t-PA and collagenase is selective. However, heparin might be affecting only those genes in which the TRE has a dominant role in transcription. For instance, the TRE is located adjacent to a serum response element in c-fos. 48 Studies have demonstrated that mutations in the serum response element eliminate epidermal growth factor or PMA stimulation of c-fos, whereas mutations in the TRE have no effect in the presence of an intact serum response element. 49, 50 In summary, heparin suppresses the induction of two different kinds of protease, t-PA and collagenase. Results from this study demonstrate that heparin suppresses the TRE-mediated collagenase gene transcription. Although a number of questions remain unanswered, we think that by exploring this phenomenon we may be able to define the mechanism of heparin's action.
